evidence: Although the median of the highest VRS scores of nausea intensity during study period was similar between the groups, the number of patients with moderate to severe nausea was significantly lower in the RD group (P = 0.029).
intervention: ramosetron group (group R
comparator: ramosetron plus dexamethasone group (group RD)
outcome: moderate to severe nausea